Although MC4R-KO mice did not develop liver tumors at this time point, the ‘pathways in cancer’ were activated in NASH-fib compared with HSCs and CCl4-fib (Fig. 2b and d). Here, MC4R is linked to metabolic dysfunction-associated steatohepatitis.